Fang W, Piao Z, Simon D, Sheu J C, Huang S
Program in Oncogenes and Tumor Suppressor Genes, The Burnham Institute, La Jolla, California.
Genes Chromosomes Cancer. 2000 Jul;28(3):269-75.
Human chromosome band 1p36 commonly undergoes loss of heterozygosity (LOH) in hepatocellular carcinoma (HCC) but the minimal deleted region remains to be mapped. This chromosomal region contains a candidate HCC suppressor gene, RIZ (PRDM2), that is a member of the PR (PRDI-BF1-RIZ homology)-domain-containing zinc finger gene family. One characteristic of this family is the unusual yin-yang involvement in human cancers. The PR-domain-containing RIZ1 product of the RIZ locus, in contrast to the PR-domain-minus product RIZ2, is commonly lost or underexpressed in HCC. Furthermore, RIZ1 can induce cell cycle arrest, apoptosis, or both and suppress HCC tumorigenicity in nude mice. To help identify the putative HCC locus on 1p36 and to evaluate a genetic role of RIZ in HCC, we studied 97 HCC cases and mapped a minimal deleted region in HCC to 1p36.13-p36. 23 between markers D1S434 and D1S436. Notably, RIZ mapped within this region and was found to undergo LOH in 37% (25/67) of HCC cases. Single-strand conformation polymorphism (SSCP) analysis, however, did not show mutations in the PR-domain region of RIZ1 in 49 cases of HCC examined. Our data suggest that the RIZ locus is a target of frequent deletion in HCC, but that the more common way of RIZ inactivation in HCC may not involve mutations that alter peptide sequences. Genes Chromosomes Cancer 28:269-275, 2000.
人类染色体1p36区域在肝细胞癌(HCC)中常发生杂合性缺失(LOH),但最小缺失区域仍有待定位。该染色体区域包含一个候选的HCC抑癌基因RIZ(PRDM2),它是含PR(PRDI - BF1 - RIZ同源性)结构域的锌指基因家族的成员。该家族的一个特点是在人类癌症中存在不寻常的阴阳作用。与不含PR结构域的产物RIZ2相比,RIZ基因座含PR结构域的RIZ1产物在HCC中通常缺失或表达不足。此外,RIZ1可诱导细胞周期停滞、凋亡或两者兼而有之,并抑制裸鼠中的HCC致瘤性。为了帮助确定1p36上假定的HCC基因座并评估RIZ在HCC中的遗传作用,我们研究了97例HCC病例,并将HCC中的最小缺失区域定位到标记D1S434和D1S436之间的1p36.13 - p36.23。值得注意的是,RIZ定位于该区域内,并且在37%(25/67)的HCC病例中发现发生了LOH。然而,在检测的49例HCC病例中,单链构象多态性(SSCP)分析未显示RIZ1的PR结构域区域存在突变。我们的数据表明,RIZ基因座是HCC中频繁缺失的靶点,但HCC中RIZ失活的更常见方式可能不涉及改变肽序列的突变。《基因、染色体与癌症》28:269 - 275,2000年。